2021 UKKA临床实践指南：SGLT-2抑制剂在成人肾脏病患者中的应用

2021-10-18 英国肾脏病协会 UKKA官网

2021年10月，英国肾脏病协会(UKKA)发布了SGLT-2抑制剂在成人肾脏病患者中的应用指南。钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂最初用于治疗2型糖尿病患者高血糖。

中文标题：

英文标题：

UK Kidney Association Clinical Practice Guideline:

发布机构：

英国肾脏病协会

发布日期：

2021-10-18

简要介绍：

2021年10月，英国肾脏病协会(UKKA)发布了SGLT-2抑制剂在成人肾脏病患者中的应用指南。钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂最初用于治疗2型糖尿病患者高血糖。已有大型试验将焦点转移到SGLT-2抑制控制心-肾风险的潜力。本文主要针对成人肾脏病患者应用SGLT-2抑制剂提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=e16df1c002288e68, title=2021 UKKA临床实践指南：SGLT-2抑制剂在成人肾脏病患者中的应用, enTitle=UK Kidney Association Clinical Practice Guideline:, guiderFrom=UKKA官网, authorId=0, author=, summary=2021年10月，英国肾脏病协会(UKKA)发布了SGLT-2抑制剂在成人肾脏病患者中的应用指南。钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂最初用于治疗2型糖尿病患者高血糖。, cover=https://img.medsci.cn/20211210/1639126598593_1608702.png, journalId=0, articlesId=null, associationId=2212, associationName=英国肾脏病协会, associationIntro=英国肾脏病协会(UKKA,UK Kidney Association), copyright=0, guiderPublishedTime=Mon Oct 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，英国肾脏病协会(UKKA)发布了SGLT-2抑制剂在成人肾脏病患者中的应用指南。钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂最初用于治疗2型糖尿病患者高血糖。已有大型试验将焦点转移到SGLT-2抑制控制心-肾风险的潜力。本文主要针对成人肾脏病患者应用SGLT-2抑制剂提供指导建议。</span></p>, tagList=[TagDto(tagId=29077, tagName=SGLT-2抑制剂)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=29077, guiderKeyword=SGLT-2抑制剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3710, appHits=137, showAppHits=0, pcHits=466, showPcHits=3573, likes=1, shares=13, comments=6, approvalStatus=1, publishedTime=Sat Dec 11 12:31:44 CST 2021, publishedTimeString=2021-10-18, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Dec 10 17:01:16 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 04:33:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 UKKA临床实践指南：SGLT-2抑制剂在成人肾脏病患者中的应用.pdf)])

2021 UKKA临床实践指南：SGLT-2抑制剂在成人肾脏病患者中的应用.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1196630, encodeId=a141119663076, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Wed Feb 23 23:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082430, encodeId=f3ef1082430d0, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:56:02 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081209, encodeId=e7571081209b9, content=血糖正常者可以用吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Fri Dec 17 17:30:55 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081070, encodeId=743d10810e06a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80183032801, createdName=772392618, createdTime=Fri Dec 17 10:26:47 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080174, encodeId=042c10801e4a7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 15 07:01:15 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
2022-02-23 ms6403861061114688

学习了

68 0
[GetPortalCommentsPageByObjectIdResponse(id=1196630, encodeId=a141119663076, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Wed Feb 23 23:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082430, encodeId=f3ef1082430d0, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:56:02 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081209, encodeId=e7571081209b9, content=血糖正常者可以用吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Fri Dec 17 17:30:55 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081070, encodeId=743d10810e06a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80183032801, createdName=772392618, createdTime=Fri Dec 17 10:26:47 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080174, encodeId=042c10801e4a7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 15 07:01:15 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
2021-12-21 龙珠

学习好资料！

86 0
[GetPortalCommentsPageByObjectIdResponse(id=1196630, encodeId=a141119663076, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Wed Feb 23 23:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082430, encodeId=f3ef1082430d0, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:56:02 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081209, encodeId=e7571081209b9, content=血糖正常者可以用吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Fri Dec 17 17:30:55 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081070, encodeId=743d10810e06a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80183032801, createdName=772392618, createdTime=Fri Dec 17 10:26:47 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080174, encodeId=042c10801e4a7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 15 07:01:15 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
2021-12-17 ms8000000897014883

血糖正常者可以用吗

85 0
[GetPortalCommentsPageByObjectIdResponse(id=1196630, encodeId=a141119663076, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Wed Feb 23 23:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082430, encodeId=f3ef1082430d0, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:56:02 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081209, encodeId=e7571081209b9, content=血糖正常者可以用吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Fri Dec 17 17:30:55 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081070, encodeId=743d10810e06a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80183032801, createdName=772392618, createdTime=Fri Dec 17 10:26:47 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080174, encodeId=042c10801e4a7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 15 07:01:15 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
2021-12-17 772392618

学习了

114 0
[GetPortalCommentsPageByObjectIdResponse(id=1196630, encodeId=a141119663076, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Wed Feb 23 23:58:56 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082430, encodeId=f3ef1082430d0, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:56:02 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081209, encodeId=e7571081209b9, content=血糖正常者可以用吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Fri Dec 17 17:30:55 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081070, encodeId=743d10810e06a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80183032801, createdName=772392618, createdTime=Fri Dec 17 10:26:47 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080174, encodeId=042c10801e4a7, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 15 07:01:15 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
2021-12-15 微探

学习学习

89 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肾内科指南

2021 UKKA临床实践指南：SGLT-2抑制剂在成人肾脏病患者中的应用

相关指南

拓展阅读

科室

工具

服务